HIM
IDXX icon

Hanlon Investment Management’s Idexx Laboratories IDXX Stock Holding History

Hanlon Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,314
Closed -$2.83M – 67
2017
Q1 		$2.83M Buy
+18,314
New +$2.52M 0.35% 33

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Hanlon Investment Management's IDXX Position: Q2 2017 in Review

Hanlon Investment Management sold out of Idexx Laboratories (IDXX) in Q2 2017, closing a stake of 18,314 shares — an estimated $2.83M sold.

Hanlon Investment Management first reported a position in IDXX in Q1 2017 and held it in 1 quarter. The position peaked at $2.83M in Q1 2017. 582 funds tracked by Wall St. Rank hold IDXX as of Q2 2017.

  • Hanlon Investment Management reported no remaining Idexx Laboratories position as of Q2 2017 after selling out during the quarter.
  • Hanlon Investment Management sold 18,314 Idexx Laboratories shares in Q2 2017, an estimated $2.83M.
  • Hanlon Investment Management first reported a position in Idexx Laboratories in Q1 2017 and held it in 1 quarter.
  • Hanlon Investment Management's Idexx Laboratories position peaked at $2.83M in Q1 2017.
  • 582 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2017.

Based on Hanlon Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.